// App-Quantinova.ai

481 : Circulating tumor cell kinetics in mRCC patients treated with sunitinib.

Researchers

Presenter

  • Kriti Mittal

Principal Investigators

  • Anthony Williams

  • Siddarth Rawal

  • Ram H Datar

  • Yu-Chong Tai

  • Richard J. Cote

  • Brian I. Rini

  • Vyshak Alva Venur

  • Bo Lu

  • Jorge Torres-Munoz

  • Ernest C. Borden

  • Zheng Ao

  • Martin OMalley

  • Laura S. Wood

  • Siyang Zheng

Medical Centers

  • University of Miami, Miami, FL

  • Cleveland Clinic, Cleveland, OH

  • Cleveland Clinic Foundation, Cleveland, OH

  • University of Miami Miller School of Medicine, Miami, FL

  • California Institute of Technology, Pasadena, CA.

  • University of Miami Miller School of Medicine, Miami, FL

  • Pennsylvania State University, University Park, PA.

  • Fairview Hosp Cleveland Clinic Hospital, Cleveland, OH

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic Renal Cell Cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Translocator protein

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Sunitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved